Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus

NARecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 14, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

September 30, 2026

Conditions
Brittle Type 1 Diabetes Mellitus
Interventions
PROCEDURE

The method of islet transplantation is through percutaneous transhepatic portal vein puncture.

The method of islet transplantation is through percutaneous transhepatic portal vein puncture.After transplantation, rabbit anti human thymocyte immunoglobulin (ATG) or basiliximab was used as induction therapy and low-dose tacrolimus combined with sirolimus or mycophenolate mofetil were used as immunosuppressive maintenance therapy.

Trial Locations (1)

Unknown

RECRUITING

Shanghai Changzheng Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Changzheng Hospital

OTHER